Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Revenue

In the year 2024, Lyell Immunopharma had annual revenue of $61.00K, down -53.08%. Lyell Immunopharma had revenue of $11.00K in the quarter ending December 31, 2024, a decrease of -15.38%.

• Revenue (ttm): $61.00K
• Revenue Growth: -53.08%
• P/S Ratio: 2,619.31
• Revenue / Employee: $203
• Employees: 300
• Market Cap: 153.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	61.00K	-69.00K	-53.08%
Dec 31, 2023	130.00K	-84.55M	-99.85%
Dec 31, 2022	84.68M	74.03M	695.15%
Dec 31, 2021	10.65M	2.89M	37.31%
Dec 31, 2020	7.76M	7.10M	1,080.52%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.